| Literature DB >> 34916727 |
Kazuyoshi Kobayashi1, Kei Ando1, Hiroaki Nakashima1, Yusuke Suzuki2, Yoshimasa Nagao3, Shiro Imagama1.
Abstract
Falls are common in elderly patients, and prevention of fall is important for safety and for reduction of health care costs. Sleep medications are among many potential causes of fall. In this study, we examined relationship of sleep medication with fall from January 2017 to December 2017. 726 falls occurred in 442 patients, and the average age at the time of fall was 60.7 ± 23.8 years. Fall was most common in patients with neurological disease, followed by gastroenterological, ophthalmological, respiratory, and orthopedic conditions. Sleep medication was used in 223 falls (31%). Fall occurred at all times of day, but with a different distribution in patients with and without use of sleep medication. Thus, the rate of falls from 22:00 to 6:00 was significantly higher in patients using sleep medication (62% vs. 18%, p<0.01). There was also a significantly higher rate of multiple falls in patient using sleep medication (p<0.01). Zolpidem (25%, n=63), a non-benzodiazepine, was the most frequently used sleep medication, followed by brotizolam (16%, n=41) and etizolam (13%, n=32), which are both benzodiazepines. Multiple falls from 22:00 to 6:00 occurred significantly more frequently in patients using ≥2 types of sleep medications compared to one (53% vs. 17%, p<0.01). Taking multiple sleeping pills makes it easier to fall, and even drugs with a short half-life, which are considered to be safe, can cause falls at night in elderly patients. The results of this study show that careful selection of sleep medications is required to prevent fall in elderly patients.Entities:
Keywords: elderly patients; fall; hospitalization; risk management; sleep medication
Mesh:
Substances:
Year: 2021 PMID: 34916727 PMCID: PMC8648538 DOI: 10.18999/nagjms.83.4.851
Source DB: PubMed Journal: Nagoya J Med Sci ISSN: 0027-7622 Impact factor: 1.131
Risk assessment score sheet a
| Assessment | Yes | No |
| Past history | ||
| History of fall | 1 | 0 |
| History of syncope | 1 | 0 |
| History of convulsions | 1 | 0 |
| Impairment | ||
| Visual impairment | 1 | 0 |
| Hearing impairment | 1 | 0 |
| Vertigo | 1 | 0 |
| Mobility | ||
| Wheelchair | 1 | 0 |
| Cane | 1 | 0 |
| Walker | 1 | 0 |
| Need assistance | 1 | 0 |
| Cognition | ||
| Disturbance of consciousness | 1 | 0 |
| Restlessness | 1 | 0 |
| Memory disturbance | 1 | 0 |
| Decreased judgment | 1 | 0 |
| Dysuria | ||
| Incontinence | 1 | 0 |
| Frequent urination | 1 | 0 |
| Need helper | 1 | 0 |
| Go to bathroom often at night | 1 | 0 |
| Difficult to reach the toilet | 1 | 0 |
| Drug use | ||
| Sleeping pills | 1 | 0 |
| Psychotropic drugs | 1 | 0 |
| Morphine | 1 | 0 |
| Painkiller | 1 | 0 |
| Antiparkinson drug | 1 | 0 |
| Antihypertensive medication | 1 | 0 |
| Anticancer agents | 1 | 0 |
| Laxatives | 1 | 0 |
| Dysfunction | ||
| Muscle weakness | 1 | 0 |
| Paralysis, numbness | 1 | 0 |
| Dizziness | 1 | 0 |
| Bone malformation | 1 | 0 |
| Rigidity | 1 | 0 |
| Brachybasia | 1 | 0 |
a Patients were classified into three groups: Grade 1 (low risk), Grade 2 (moderate risk), and Grade 3 (high risk) based on total scores of 0–5, 6–15, and ≥16 and including at least one item in each category, respectively.
Demographics and characteristics of cases of fall
| Variable | Cases |
| Demographic | |
| Falls (n) | 726 |
| Age (years) | 60.7±23.8 |
| Sex (male/ female) | 455/271 |
| Over 80 years of age | 19% (138) |
| Over 60 years of age | 68% (493) |
| Primary disease | |
| Neurological | 27% (196) |
| Gastroenterological | 19% (138) |
| Ophthalmology | 12% (87) |
| Respiratory | 8% (58) |
| Orthopedics | 6% (44) |
| Cardiac | 5% (37) |
| Pediatrics | 5% (35) |
| Otolaryngology | 5% (34) |
| Genecology | 4% (29) |
| Others | 9% (68) |
| Fall risk score | |
| Grade 1 | 12% (87) |
| Grade 2 | 45% (327) |
| Grade 3 | 43% (312) |
| Location | |
| Hospital room | 66% (479) |
| Corridor | 13% (94) |
| Restroom | 8% (58) |
| Bathroom | 4% (29) |
| Rehabilitation ward | 2% (15) |
| Others | 7% (51) |
| Number of falls (per patient) | |
| Once | 51% (225) |
| Twice | 38% (170) |
| Three or more times | 11% (47) |
| Falls with sleep medication | 31% (223) |
Fig. 1Distribution of falls
Distribution of falls by age category.
Fig. 2Trends of falls
Distribution of falls by time, including in patients with and without sleep medication.
Fig. 3Details of falls
Relationship between “fall from 22:00 to 6:00” and “sleep medication”.
Fig. 3A: Rate of falls from 22:00 to 6:00 in patients with sleep medication.
Fig. 3B: Percentage of falls from 22:00 to 6:00 in patients with and without sleep medication (62% vs. 18%, p<0.01).
Comparison of falls with and without use of sleep medication
| Variable | Falls with
| Falls without
| |
| Demographic | |||
| Age (years) | 64.1±22.4 | 59.2±23.7 | <0.05 |
| Female | 36% (80) | 38% (191) | n.s. |
| Over 80 years of age | 30% (68) | 18% (93) | <0.01 |
| Over 60 years of age | 82% (183) | 62% (310) | <0.01 |
| Fall risk score | |||
| Grade I | 11% (26) | 12% (61) | n.s. |
| Grade II | 46% (103) | 45% (224) | n.s. |
| Grade III | 42% (94) | 43% (218) | n.s. |
| Location | |||
| Hospital room | 63% (141) | 67% (338) | n.s. |
| Corridor | 16% (35) | 12% (59) | n.s. |
| Restroom | 9% (19) | 8% (39) | n.s. |
| Bathroom | 4% (9) | 4% (20) | n.s. |
| Rehabilitation ward | 2% (5) | 2% (10) | n.s. |
| Others | 6% (14) | 7% (37) | n.s. |
Comparison of number of falls with and without use of sleep medication
| Variable | Patients with
| Patients without
| |
| Number of falls (per patient) | |||
| Once | 37% (47) | 57% (178) | <0.01 |
| Twice | 39% (50) | 38% (120) | n.s. |
| Three or more times | 24% (30) | 5% (17) | <0.01 |
Details of use of sleep medications in patients with falls
| Classification | Drug name | n |
| Very short half-life | Zolpidem (Myslee®) | 25% (63) |
| Zopiclone (Amoban®) | 8% (21) | |
| Eszopiclone (Lunesta®) | 8% (19) | |
| Short half-life | Brotizolam (Lendormin®) b | 16% (41) |
| Etizolam (Depas®) b | 13% (32) | |
| Rilmazafone (Rhythmy®) b | 3% (7) | |
| Intermediate half-life | Flunitrazepam (Silece®) b | 4% (9) |
| Nitrazepam (Benzarin®) b | 2% (4) | |
| Long half-life | Quazepam (Doral®) b | 2% (6) |
| Others | Ramelteon (Rozerem®) | 12% (29) |
| Suvorexant (Belsomra®) | 8% (19) | |
| Total | 250 a |
a Overlap in some cases
b Benzodiazepine
Fig. 4Details of falls from 22:00 to 6:00 with sleep medication
Percentage of ≥2 falls from 22:00 to 6:00 in patients with ≥2 and only 1 type of sleep medication (53% vs. 17%, p<0.01).